drugset / Trial / NCT04022811

Effect of Bromfenac on Pain Related to Pterygium Surgery

NCT04022811

NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy and ocular safety of bromfenac ophthalmic solution (bromfenac) 0.1% dosed twice daily for the treatment of ocular inflammation and pain after pterygium excision with amniotic membrane transplantation(AMT).

Timeline

Start
2016-10
Primary completion
2017-10
Completion
2017-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromfenac Other / unclassified 0.1 % Topical

Indications